Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

8.79 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -95.496-188.917-142.181-72.754-43.843-16.984
Depreciation & Amortization 1.5620.3830.5310.1990.1550
Deferred Income Tax 000000
Stock Based Compensation 48.26339.34127.24213.3210.5260.111
Change In Working Capital 09.4186.5642.695-0.3570.444
Accounts Receivables -13.87600000
Inventory -3.24300000
Accounts Payables 0.6862.316-1.4841.5420.1320.014
Other Working Capital 07.1028.0481.153-0.4890.43
Other Non Cash Items -32.442-7.078-2.03830.0311.914
Operating Cash Flow -78.113-146.853-109.874-48.539-13.489-4.515
Investing Activities:
Investments In Property Plant And Equipment -2.169-0.224-0.026-8-0.0920
Acquisitions Net 000.255000
Purchases Of Investments -658.616-443.838-394.206000
Sales Maturities Of Investments 393.891575.44139.158000
Other Investing Activites 35.9-3-0.255-800
Investing Cash Flow -230.994128.378-255.074-8-0.0920
Financing Activities:
Debt Repayment 000001
Common Stock Issued 178.177161.409161.61167.04529.97729.905
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 25.1145.1764.291130.07529.97729.905
Financing Cash Flow 203.291163.997165.901297.1229.97730.905
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -105.816145.522-199.047240.58116.39626.39
Cash At End Of Period 124.968230.78485.262284.30943.72827.332